ReviewCurrent allergy and asthma reports2003
The role of epinephrine in the treatment of anaphylaxis.
Review in Current allergy and asthma reports, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Contrast-induced anaphylaxis: does it occur in the medical environment and is it being responded to appropriately?Japanese journal of radiology · 2023Article
- Diclofenac induced anaphylaxis: A case report from Nepal.Annals of medicine and surgery (2012) · 2022Article
- Anaphylaxis in Omani Patients: A Study from a Tertiary Care Center.Oman medical journal · 2022Article
- Outpatient Emergencies: Anaphylaxis.The Medical clinics of North America · 2017Review
- Anaphylactic reaction to intravenous diclofenac.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2011Article
- [Out-of-Hospital treatment of anaphylactoid reactions].Der Internist · 2004Review
- Adrenaline in the treatment of anaphylaxis: what is the evidence?BMJ (Clinical research ed.) · 2003Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epinephrine is the cornerstone of anaphylaxis management. Its administration should be immediate upon evidence of the occurrence of anaphylaxis. Delays in administration may be fatal. The most appropriate administration is 0.3 to 0.5 mL of 1:1000 dilution intramuscularly for adults and 0.01 mg/kg for children, given in the lateral thigh. Patients with known anaphylactic reactivity should be prescribed an epinephrine auto-injector to be carried at all times for treatment of potential recurrences. Education of the patient or parent regarding the proper use of this tool is paramount.
Indexed as
Identifiers
12542987What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.